DK1545553T3 - Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter - Google Patents

Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Info

Publication number
DK1545553T3
DK1545553T3 DK03766336.6T DK03766336T DK1545553T3 DK 1545553 T3 DK1545553 T3 DK 1545553T3 DK 03766336 T DK03766336 T DK 03766336T DK 1545553 T3 DK1545553 T3 DK 1545553T3
Authority
DK
Denmark
Prior art keywords
alkylphosphocholines
combination
antitumor drugs
antitumor
drugs
Prior art date
Application number
DK03766336.6T
Other languages
Danish (da)
English (en)
Inventor
Herbert Sindermann
Juergen Engel
Eckhard Guenther
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Zentaris Gmbh filed Critical Aeterna Zentaris Gmbh
Application granted granted Critical
Publication of DK1545553T3 publication Critical patent/DK1545553T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03766336.6T 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter DK1545553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30
PCT/EP2003/008346 WO2004012744A1 (de) 2002-07-30 2003-07-29 Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten

Publications (1)

Publication Number Publication Date
DK1545553T3 true DK1545553T3 (da) 2011-09-12

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03766336.6T DK1545553T3 (da) 2002-07-30 2003-07-29 Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter

Country Status (26)

Country Link
US (3) US8389497B2 (enExample)
EP (2) EP1545553B1 (enExample)
JP (1) JP2005535688A (enExample)
KR (3) KR101066804B1 (enExample)
CN (1) CN1302780C (enExample)
AR (1) AR040717A1 (enExample)
AT (1) ATE516036T1 (enExample)
AU (2) AU2003253350B2 (enExample)
BR (1) BR0313048A (enExample)
CA (1) CA2493023C (enExample)
CY (1) CY1111902T1 (enExample)
DK (1) DK1545553T3 (enExample)
ES (1) ES2369535T3 (enExample)
HR (1) HRP20050184B1 (enExample)
IL (1) IL166329A (enExample)
MX (1) MXPA05001203A (enExample)
NO (1) NO335196B1 (enExample)
NZ (1) NZ538428A (enExample)
PL (1) PL375493A1 (enExample)
PT (1) PT1545553E (enExample)
RU (1) RU2005105693A (enExample)
SI (1) SI1545553T1 (enExample)
TW (1) TWI332007B (enExample)
UA (1) UA82322C2 (enExample)
WO (1) WO2004012744A1 (enExample)
ZA (1) ZA200500453B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
TWI332007B (en) 2002-07-30 2010-10-21 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals
DE10324911B4 (de) 2003-05-30 2005-08-18 Siemens Ag Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
WO2009018233A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
CN101340918B (zh) * 2005-12-19 2012-10-03 阿特纳赞塔里斯有限公司 具有降低细胞毒性的新烷基磷脂衍生物及其用途
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
MX2011006167A (es) * 2008-12-11 2011-07-28 Abraxis Bioscience Llc Combinaciones y modos de administracion de agentes terapeuticos y terapia de combinacion.
MX2011011596A (es) 2010-03-31 2012-02-01 Keryx Biopharmaceuticals Inc Perifosina y capecitabina como un tratamiento combinado para cancer.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59205998D1 (de) * 1991-07-04 1996-05-23 Asta Medica Ag Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
PL189654B1 (pl) * 1998-01-22 2005-09-30 Zentaris Gmbh Zastosowanie miltefosyny do wytwarzania leków
PT1135193E (pt) * 1998-12-04 2003-01-31 Max Delbrueck Centrum Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno
CA2356736A1 (en) * 1998-12-21 2000-06-29 Inkeysa. S.A. Use of etherlysophospholipids as antiinflammatory agents
EP2762140B1 (en) * 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
PL365285A1 (en) * 2001-03-23 2004-12-27 Shire Biochem Inc. Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
US20060084612A1 (en) * 2002-01-02 2006-04-20 Geroni Maria C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
TWI332007B (en) 2002-07-30 2010-10-21 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
CN101340918B (zh) * 2005-12-19 2012-10-03 阿特纳赞塔里斯有限公司 具有降低细胞毒性的新烷基磷脂衍生物及其用途
MX2011011596A (es) * 2010-03-31 2012-02-01 Keryx Biopharmaceuticals Inc Perifosina y capecitabina como un tratamiento combinado para cancer.

Also Published As

Publication number Publication date
HRP20050184A2 (en) 2005-04-30
PL375493A1 (en) 2005-11-28
US8389497B2 (en) 2013-03-05
JP2005535688A (ja) 2005-11-24
IL166329A0 (en) 2006-01-15
NO20051040L (no) 2005-02-25
US8507710B2 (en) 2013-08-13
IL166329A (en) 2012-08-30
US20100190738A1 (en) 2010-07-29
KR20130016413A (ko) 2013-02-14
TWI332007B (en) 2010-10-21
CY1111902T1 (el) 2015-11-04
EP1545553A1 (de) 2005-06-29
US20100189784A1 (en) 2010-07-29
CN1302780C (zh) 2007-03-07
SI1545553T1 (sl) 2011-09-30
HRP20050184B1 (hr) 2014-04-11
KR20110102485A (ko) 2011-09-16
US8551977B2 (en) 2013-10-08
RU2005105693A (ru) 2005-07-10
KR101066804B1 (ko) 2011-09-22
AU2003253350B2 (en) 2008-06-26
CA2493023A1 (en) 2004-02-12
ATE516036T1 (de) 2011-07-15
NO335196B1 (no) 2014-10-20
PT1545553E (pt) 2011-09-12
WO2004012744A1 (de) 2004-02-12
ZA200500453B (en) 2005-08-31
KR20050026028A (ko) 2005-03-14
EP2301551A1 (de) 2011-03-30
TW200404073A (en) 2004-03-16
MXPA05001203A (es) 2005-06-08
BR0313048A (pt) 2005-06-14
CN1671397A (zh) 2005-09-21
CA2493023C (en) 2012-01-31
NZ538428A (en) 2006-09-29
AR040717A1 (es) 2005-04-20
EP1545553B1 (de) 2011-07-13
AU2008203060B2 (en) 2011-04-21
ES2369535T3 (es) 2011-12-01
AU2003253350A1 (en) 2004-02-23
HK1080751A1 (en) 2006-05-04
US20040097470A1 (en) 2004-05-20
AU2008203060A1 (en) 2008-07-31
UA82322C2 (uk) 2008-04-10

Similar Documents

Publication Publication Date Title
NO2024034I1 (no) Elvitegravir and tenofovir alafenamide
EP1682989A4 (en) SYNCHRONIZATION AND FUSION ENGINES
DK2609948T3 (da) Infusionsindretning i form af plaster
DE602005007068D1 (de) Steckdose mit gegenschutz und ausrichtungsmitteln
NO20031447L (no) Paclitaxel-basert antitumor-formulering
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
DE60327864D1 (de) Ballondissektor mit kanüle
NO20043903L (no) Azitromycindoseringsform med reduserte bivirkninger
DE602004004953D1 (de) Kochfeld mit Benutzerschnittstelle und beliebiger Positionierung
DE602004017700D1 (de) Transmukosen verabreichung
DK1581297T3 (da) Kateter med enhedsbestanddel
EP1827489A4 (en) USE OF FLAGELLIN FOR TUMORIMMUN THERAPY
EE200200607A (et) 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
NO20043313L (no) Anvendelse av COX-2 inhibitorer i kombinasjon med antivirale midler for behandling av Papilloma virus infeksjoner
NO20053529D0 (no) Lymfotoksin-beta-reseptormedikamenter i kombinasjon med kjemoterapeutiske midler
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DE602005001977D1 (de) Messtisch und optisches Messsystem
DK1545553T3 (da) Anvendelse af alkylphosphocholiner i kombination med antitumormedikamenter
PL377180A1 (pl) Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
DK1541137T3 (da) Transdermalt delivery system af gestoden
DE602005024291D1 (de) Kamerasystem und kamera-hauptkörper
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
DK1603919T3 (da) 7-Iminoderivater af camptothecin med antitumoraktivitet
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks